Check out a recent webinar featuring Dr Maria Buti, Professor of Medicine and Consultant of Hepatology at the University Hospital Vall d'Hebron in Barcelona, Spain. Dr. Buti is a leading global expert in liver disease and will be presenting an overview of her recent paper, "Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the Phase III MYR301 trial of bulevirtide." This study includes important data on health-related quality of life for individuals living with hepatitis delta. We hope you enjoy hearing Dr. Buti share insights about this important work!
25 сен 2024